MGO One Seven’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.3M | Sell |
28,149
-4,105
| -13% | -$629K | 0.09% | 269 |
|
|
2025
Q4 | $4.45M | Buy |
32,254
+5,939
| +23% | +$778K | 0.09% | 258 |
|
|
2025
Q3 | $3.37M | Buy |
26,315
+2,364
| +10% | +$288K | 0.08% | 277 |
|
|
2025
Q2 | $2.9M | Buy |
23,951
+644
| +3% | +$72.6K | 0.09% | 245 |
|
|
2025
Q1 | $2.6M | Sell |
23,307
-4,403
| -16% | -$469K | 0.1% | 218 |
|
|
2024
Q4 | $2.7M | Buy |
27,710
+3,042
| +12% | +$324K | 0.1% | 219 |
|
|
2024
Q3 | $2.84M | Sell |
24,668
-1,779
| -7% | -$202K | 0.12% | 187 |
|
|
2024
Q2 | $2.82M | Sell |
26,447
-630
| -2% | -$63.2K | 0.13% | 176 |
|
|
2024
Q1 | $2.62M | Sell |
27,077
-6,889
| -20% | -$706K | 0.14% | 174 |
|
|
2023
Q4 | $3.43M | Buy |
33,966
+2,054
| +6% | +$198K | 0.2% | 125 |
|
|
2023
Q3 | $3.25M | Sell |
31,912
-1,005
| -3% | -$102K | 0.25% | 96 |
|
|
2023
Q2 | $3.32M | Sell |
32,917
-1,301
| -4% | -$130K | 0.3% | 71 |
|
|
2023
Q1 | $3.15M | Buy |
34,218
+1,263
| +4% | +$110K | 0.2% | 133 |
|
|
2022
Q4 | $2.99M | Buy |
32,955
+1,965
| +6% | +$166K | 0.3% | 80 |
|
|
2022
Q3 | $4.03K | Buy |
30,990
+3,118
| +11% | +$258K | 0.16% | 88 |
|
|
2022
Q2 | $2.36M | Sell |
27,872
-4,686
| -14% | -$411K | 0.32% | 68 |
|
|
2022
Q1 | $2.45M | Sell |
32,558
-372
| -1% | -$32.2K | 0.26% | 92 |
|
|
2021
Q4 | $2.48M | Sell |
32,930
-1,133
| -3% | -$94.1K | 0.26% | 94 |
|
|
2021
Q3 | $2.44M | Sell |
34,063
-201
| -0.6% | -$18.1K | 0.31% | 82 |
|
|
2021
Q2 | $2.7M | Sell |
34,264
-59
| -0.2% | -$5.25K | 0.38% | 58 |
|
|
2021
Q1 | $2.54M | Sell |
34,323
-7,338
| -18% | -$659K | 0.44% | 43 |
|
|
2020
Q4 | $3.5M | Sell |
41,661
-1,209
| -3% | -$106K | 0.72% | 22 |
|
|
2020
Q3 | $3.33M | Sell |
42,870
-2,885
| -6% | -$250K | 0.79% | 17 |
|
|
2020
Q2 | $3.59M | Buy |
45,755
+4,882
| +12% | +$421K | 0.93% | 14 |
|
|
2020
Q1 | $3.37M | Buy |
40,873
+254
| +0.6% | +$22.7K | 1.14% | 12 |
|
|
2019
Q4 | $3.85M | Buy |
40,619
+2,154
| +6% | +$193K | 1% | 13 |
|
|
2019
Q3 | $3.34M | Buy |
38,465
+2,803
| +8% | +$252K | 0.96% | 15 |
|
|
2019
Q2 | $3.26M | Buy |
35,662
+3,814
| +12% | +$323K | 1.05% | 12 |
|
|
2019
Q1 | $2.74M | Buy |
31,848
+15,803
| +98% | +$1.27M | 0.89% | 13 |
|
|
2018
Q4 | $1.23M | Buy |
16,045
+1,324
| +9% | +$103K | 0.53% | 31 |
|
|
2018
Q3 | $1.14M | Buy |
+14,721
| New | +$1.09M | 0.53% | 38 |
|
|
2018
Q1 | $1.02M | Sell |
14,096
-1,027
| -7% | -$78.2K | 0.47% | 33 |
|
|
2017
Q4 | $1.14M | Buy |
+15,123
| New | +$1.14M | 0.53% | 30 |
|
Other funds holding NVS
MGO One Seven's NVS Position: Q1 2026 in Review
MGO One Seven reduced its Novartis (NVS) stake by 13% in Q1 2026, selling an estimated $629K and leaving 28,149 shares worth $4.3M. The position accounts for 0.09% of the portfolio, ranked #269.
MGO One Seven first reported a position in NVS in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.45M in Q4 2025. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- MGO One Seven held 28,149 shares of Novartis worth $4.3M as of Q1 2026.
- MGO One Seven sold 4,105 Novartis shares in Q1 2026, an estimated $629K.
- Novartis made up 0.09% of MGO One Seven's portfolio in Q1 2026, its #269 holding.
- MGO One Seven first reported a position in Novartis in Q4 2017 and has held it in 33 quarters since.
- MGO One Seven's Novartis position peaked at $4.45M in Q4 2025.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.